
TechTalk: Automated measurement of BD-Tau and BD-p217-Tau in blood
Friday, October 16 at 15:00 BST | 16:00 CEST | 10:00 EDT | 7:00 PDT
Accurate measurement of brain-derived Tau (BD-Tau) and phosphorylated Tau (BD-p217 Tau) in blood is becoming increasingly important in Alzheimer’s disease and neurodegeneration research. However, established manual workflows can be time-consuming and may introduce variability, making it more difficult to achieve consistent, reproducible results.
In this SelectScience® TechTalk, join Oliver Schmidt, Tecan, to discover how two key neurodegeneration biomarkers, BD-Tau and BD-p217 Tau, can be applied on the TECAN Fluent® 780 instrument. He will explore their role in neurodegeneration research and demonstrate how automated workflows can support more efficient and consistent biomarker measurement.
You will gain practical insight into the application of BD-Tau and BD-p217 Tau assays, the advantages of moving away from manual procedures, and how automation can help streamline blood-based biomarker analysis for Alzheimer’s disease research.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available
Speakers

Who should attend?
- Neurodegeneration researchers
- Neurologists
What will this webinar cover?
Join the TechTalk to get answers to these questions:
- What roles do BD-Tau and BD-p217 Tau play in neurodegeneration research?
- How can these biomarkers support Alzheimer’s disease research?
- How are BD-Tau and BD-p217 Tau assays applied on the TECAN Fluent 780?
- What advantages does automation offer over manual workflows?
- How can automation improve the efficiency, consistency, and reproducibility of blood-based biomarker analysis?
